Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
- PMID: 9751496
- DOI: 10.1210/endo.139.10.6229
Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
Abstract
Hormone-dependent breast cancer responds to primary therapies that block estrogen production or action, but tumor regrowth often occurs 12-18 months later. Additional hormonal treatments that further reduce estrogen synthesis or more effectively block its action cause additional remissions, but the mechanisms responsible for these secondary responses are not well understood. As a working hypothesis, we postulated that primary hormonal therapy induces adaptive changes, resulting in enhanced estrogen receptor (ER) expression and target gene activation and, further, that secondary treatment modalities interfere with these receptor-mediated transcriptional pathways. To test this hypothesis, we used an MCF-7 breast cancer model system involving deprivation of estradiol in culture for a prolonged period. These long-term estradiol-deprived (LTED) cells adapt by acquiring the ability to regrow in the absence of added estradiol. The experimental paradigm involved the comparison of wild-type cells with LTED cells. As endpoints, we directly assessed ER expression at the messenger RNA-, protein-, and ligand-binding levels and ER functionality by quantitating reporter gene activation and expression of endogenous estrogen target gene messenger RNA, as well as ER coactivator levels. Our data demonstrated an adaptive increase in ER expression and in basal ER functionality, as assessed by read-out of three different transfected reporters in LTED, as opposed to wild-type MCF-7 cells. Increased reporter gene read-out was dramatically inhibited by the pure antiestrogen ICI 182,780. As verification that endogenous (as well as transfected) estrogen target genes had enhanced transcription, we found that the basal levels of c-myb and c-myc message were substantially increased in LTED cells and could be inhibited by antiestrogen. Interestingly, the levels of c-myb and c-myc message in the LTED cells seemed to be increased out of proportion to the degree of ER reporter gene activation and were similar to those in wild-type cells maximally stimulated with estradiol. In addition, not all estrogen-responsive genes were activated, because transforming growth factor-alpha message level was not increased in LTED cells. Up-regulation of the steroid receptor coactivator SRC-1 did not seem to mediate the process of enhanced ER-induced transcription. Considering these observations together, we suggest that long-term estradiol deprivation causes adaptive processes that not only involve up-regulation of the ER but also influence the specificity and magnitude of activation of estrogen-responsive genes.
Similar articles
-
Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells.Breast Cancer Res Treat. 2005 Dec;94(3):213-23. doi: 10.1007/s10549-005-5776-4. Breast Cancer Res Treat. 2005. PMID: 16258703
-
Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.Breast Cancer Res Treat. 2000 Aug;62(3):167-75. doi: 10.1023/a:1006406030612. Breast Cancer Res Treat. 2000. PMID: 11072781
-
Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.Mol Cell Endocrinol. 2002 Jul 31;193(1-2):29-42. doi: 10.1016/s0303-7207(02)00093-x. Mol Cell Endocrinol. 2002. PMID: 12160999
-
Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.Endocr Relat Cancer. 2003 Jun;10(2):111-30. doi: 10.1677/erc.0.0100111. Endocr Relat Cancer. 2003. PMID: 12790774 Review.
-
Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):115-25. doi: 10.1016/s0960-0760(01)00151-0. J Steroid Biochem Mol Biol. 2001. PMID: 11850215 Review.
Cited by 46 articles
-
Nucleosome destabilization by nuclear non-coding RNAs.Commun Biol. 2020 Feb 11;3(1):60. doi: 10.1038/s42003-020-0784-9. Commun Biol. 2020. PMID: 32047236 Free PMC article.
-
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis.Nat Commun. 2019 Aug 22;10(1):3778. doi: 10.1038/s41467-019-11378-4. Nat Commun. 2019. PMID: 31439835 Free PMC article.
-
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.Sci Rep. 2018 Oct 12;8(1):15202. doi: 10.1038/s41598-018-33227-y. Sci Rep. 2018. PMID: 30315184 Free PMC article.
-
Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.Oncotarget. 2018 May 4;9(34):23451-23461. doi: 10.18632/oncotarget.25217. eCollection 2018 May 4. Oncotarget. 2018. PMID: 29805747 Free PMC article.
-
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.Oncogene. 2018 Aug;37(34):4692-4710. doi: 10.1038/s41388-018-0273-5. Epub 2018 May 14. Oncogene. 2018. PMID: 29755131 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous